1. Home
  2. SDGR vs MFA Comparison

SDGR vs MFA Comparison

Compare SDGR & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • MFA
  • Stock Information
  • Founded
  • SDGR 1990
  • MFA 1997
  • Country
  • SDGR United States
  • MFA United States
  • Employees
  • SDGR N/A
  • MFA N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • MFA Real Estate Investment Trusts
  • Sector
  • SDGR Health Care
  • MFA Real Estate
  • Exchange
  • SDGR Nasdaq
  • MFA Nasdaq
  • Market Cap
  • SDGR 1.3B
  • MFA 1.1B
  • IPO Year
  • SDGR 2020
  • MFA N/A
  • Fundamental
  • Price
  • SDGR $18.73
  • MFA $11.03
  • Analyst Decision
  • SDGR Buy
  • MFA Buy
  • Analyst Count
  • SDGR 10
  • MFA 5
  • Target Price
  • SDGR $32.90
  • MFA $13.40
  • AVG Volume (30 Days)
  • SDGR 910.2K
  • MFA 972.8K
  • Earning Date
  • SDGR 11-12-2024
  • MFA 11-06-2024
  • Dividend Yield
  • SDGR N/A
  • MFA 12.69%
  • EPS Growth
  • SDGR N/A
  • MFA N/A
  • EPS
  • SDGR N/A
  • MFA 1.60
  • Revenue
  • SDGR $193,348,000.00
  • MFA $366,192,000.00
  • Revenue This Year
  • SDGR N/A
  • MFA N/A
  • Revenue Next Year
  • SDGR $24.24
  • MFA $17.05
  • P/E Ratio
  • SDGR N/A
  • MFA $6.89
  • Revenue Growth
  • SDGR N/A
  • MFA 164.50
  • 52 Week Low
  • SDGR $16.67
  • MFA $10.20
  • 52 Week High
  • SDGR $38.00
  • MFA $13.45
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 53.47
  • MFA 29.02
  • Support Level
  • SDGR $18.42
  • MFA $10.96
  • Resistance Level
  • SDGR $23.65
  • MFA $12.60
  • Average True Range (ATR)
  • SDGR 1.00
  • MFA 0.34
  • MACD
  • SDGR 0.28
  • MFA -0.12
  • Stochastic Oscillator
  • SDGR 36.87
  • MFA 3.63

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.

Share on Social Networks: